Since their launch, IVD technologies have evolved by far, and have moved from hospital or laboratory settings to clinics or point-of-care settings. It has become a crucial element of clinical decision making and a specialized element of patient treatment. Today, the growing adoption of personalized medicine approaches is driving the technological evolution in the IVD industry.

The incorporation of microfluidic technologies in POC devices is enabling device miniaturization and rapid turnaround times. With rapidly evolving technological landscape, players in this market are struggling to match it with timely product launches and innovations

MarketsandMarketsTM is delighted to invite you to a webinar titled "In-Vitro Diagnostics – The Way Forward", which will be hosted on May 12, 2017 from 11:00 am to 12:00 pm (EST). Please join our experts – Carl Schmidt, Managing Director and Dhawal Thakur, Research Manager with our Healthcare Practice as they discuss the future of IVD technologies and revenue growth opportunities for leading players in this market.

Specific insights that you will get include:

1. How will increasing focus on personalized medicineshape the growth of IVD technologies?
2. How is regulatory landscape creating growth opportunities in emerging markets?
3. How are players managing technological competitiveness in the IVD market?
4. What are next revenue growth opportunities in the IVD industry?

Register now and get an opportunity to learn from leading industry analysts. The event would be concluded by a one-on-one Q&A